• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物抑制DNA旋转酶的分子机制。

Molecular mechanisms of drug inhibition of DNA gyrase.

作者信息

Lewis R J, Tsai F T, Wigley D B

机构信息

Laboratory of Molecular Biophysics, University of Oxford, UK.

出版信息

Bioessays. 1996 Aug;18(8):661-71. doi: 10.1002/bies.950180810.

DOI:10.1002/bies.950180810
PMID:8760340
Abstract

DNA gyrase, an enzyme unique to prokaryotes, has been implicated in almost all processes that involve DNA. Although efficient inhibitors of this protein have been known for more than 20 years, none of them have enjoyed prolonged pharmaceutical success. It is only recently that the mechanisms of inhibition for some of these classes of drugs have been established unequivocally by X-ray crystallography. It is hoped that this detailed structural information will assist the design of novel, effective inhibitors of DNA gyrase.

摘要

DNA 促旋酶是原核生物特有的一种酶,几乎参与了所有涉及 DNA 的过程。尽管这种蛋白质的有效抑制剂已被发现二十多年,但它们都未在制药领域取得长期成功。直到最近,通过 X 射线晶体学才明确确定了其中一些药物的抑制机制。人们希望这些详细的结构信息将有助于设计新型、有效的 DNA 促旋酶抑制剂。

相似文献

1
Molecular mechanisms of drug inhibition of DNA gyrase.药物抑制DNA旋转酶的分子机制。
Bioessays. 1996 Aug;18(8):661-71. doi: 10.1002/bies.950180810.
2
The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition.抗生素小菌素B17是一种DNA回旋酶毒物:抑制模式的表征。
J Mol Biol. 2001 Apr 13;307(5):1223-34. doi: 10.1006/jmbi.2001.4562.
3
DNA gyrase as a drug target.作为药物靶点的DNA促旋酶
Trends Microbiol. 1997 Mar;5(3):102-9. doi: 10.1016/S0966-842X(96)10085-8.
4
Mode of action of new quinolones: the inhibitory activity on DNA gyrase.新型喹诺酮类药物的作用机制:对DNA促旋酶的抑制活性。
Prog Drug Res. 1992;38:121-32.
5
gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity.gyrB - 225,一种补偿拓扑异构酶I缺陷的DNA促旋酶突变:对其低活性和喹诺酮超敏反应的研究
J Mol Biol. 2001 Jun 22;309(5):1219-31. doi: 10.1006/jmbi.2001.4733.
6
Testing potential gyrase inhibitors of bacterial DNA gyrase: a comparison of the supercoiling inhibition assay and "cleavable complex" assay.测试细菌DNA促旋酶的潜在抑制剂:超螺旋抑制试验与“可切割复合物”试验的比较。
Anal Biochem. 1993 Oct;214(1):313-7. doi: 10.1006/abio.1993.1493.
7
[How well do gyrase inhibitors work? The pharmacokinetics of quinolones].
Pharm Unserer Zeit. 2001;30(5):418-27. doi: 10.1002/1615-1003(200109)30:5<418::AID-PAUZ418>3.0.CO;2-#.
8
[Quinolones. Gyrase inhibitors].[喹诺酮类。回旋酶抑制剂]
Internist (Berl). 1994 May;35(5):484-9.
9
Two short peptides including segments of subunit A of Escherichia coli DNA gyrase as potential probes to evaluate the antibacterial activity of quinolones.两种包含大肠杆菌DNA促旋酶A亚基片段的短肽,作为评估喹诺酮类抗菌活性的潜在探针。
J Pept Sci. 2001 Jan;7(1):27-40. doi: 10.1002/psc.292.
10
DNA gyrase: structure and function.DNA 回旋酶:结构与功能
Crit Rev Biochem Mol Biol. 1991;26(3-4):335-75. doi: 10.3109/10409239109114072.

引用本文的文献

1
Antibiotics and Antibiotic Resistance-Mur Ligases as an Antibacterial Target.抗生素和抗生素耐药性——作为抗菌靶点的 Mur 连接酶。
Molecules. 2023 Dec 13;28(24):8076. doi: 10.3390/molecules28248076.
2
A machine learning model trained on a high-throughput antibacterial screen increases the hit rate of drug discovery.基于高通量抗菌筛选的机器学习模型提高了药物发现的命中率。
PLoS Comput Biol. 2022 Oct 13;18(10):e1010613. doi: 10.1371/journal.pcbi.1010613. eCollection 2022 Oct.
3
Molecular targets and anticancer activity of quinoline-chalcone hybrids: literature review.
喹啉-查尔酮杂合物的分子靶点与抗癌活性:文献综述
RSC Adv. 2020 Aug 21;10(52):31139-31155. doi: 10.1039/d0ra05594h.
4
Physiological Roles of DNA Double-Strand Breaks.DNA双链断裂的生理作用
J Nucleic Acids. 2017;2017:6439169. doi: 10.1155/2017/6439169. Epub 2017 Oct 18.
5
Validation of Putative Apicoplast-Targeting Drugs Using a Chemical Supplementation Assay in Cultured Human Malaria Parasites.利用化学补充测定法在培养的人类疟疾寄生虫中验证潜在的质体靶向药物。
Antimicrob Agents Chemother. 2017 Dec 21;62(1). doi: 10.1128/AAC.01161-17. Print 2018 Jan.
6
Competitive Growth Enhances Conditional Growth Mutant Sensitivity to Antibiotics and Exposes a Two-Component System as an Emerging Antibacterial Target in Burkholderia cenocepacia.竞争性生长增强了条件性生长突变体对抗生素的敏感性,并揭示了一种双组分系统作为洋葱伯克霍尔德菌中新出现的抗菌靶点。
Antimicrob Agents Chemother. 2016 Dec 27;61(1). doi: 10.1128/AAC.00790-16. Print 2017 Jan.
7
Simultaneous estimation of degree of crystallinity in combination drug product of abacavir, lamivudine and neverapine using X-ray powder diffraction technique.使用X射线粉末衍射技术同时估算阿巴卡韦、拉米夫定和奈韦拉平复方制剂的结晶度
J Young Pharm. 2013 Dec;5(4):127-32. doi: 10.1016/j.jyp.2013.10.003. Epub 2013 Nov 14.
8
Progress in the discovery of treatments for C. difficile infection: A clinical and medicinal chemistry review.艰难梭菌感染治疗方法的研究进展:临床和药物化学综述。
Curr Top Med Chem. 2014;14(1):152-75. doi: 10.2174/1568026613666131113154753.
9
Mechanism of action-based classification of antibiotics using high-content bacterial image analysis.基于作用机制,利用高内涵细菌图像分析对抗生素进行分类
Mol Biosyst. 2013 Jul;9(7):1837-48. doi: 10.1039/c3mb70027e. Epub 2013 Apr 23.
10
Burkholderia cenocepacia conditional growth mutant library created by random promoter replacement of essential genes.随机替换必需基因启动子构建洋葱伯克霍尔德菌条件生长突变体库。
Microbiologyopen. 2013 Apr;2(2):243-58. doi: 10.1002/mbo3.71. Epub 2013 Feb 7.